Resources
Related Tags:
Medicis Pharmaceutical Corp. (9 results)
- sort by:
- Relevance
- Date
- Popularity
- MedStar EMS Selects Philips HeartStart MRx Monitor/Defibrillators with Q-CPR to Enhance Emergency Cardiac Care
- FORT WORTH, Texas -- MedStar EMS, the 911 provider of Fort Worth, and 14 surrounding cities, has outfitted its fleet of emergency vehicles with Philips HeartStart MRx Monitor/Defibrillators with Q-CPR technology, to enhance care for patients with cardiac emergencies. The Philips HeartStart MRx is a monitor/defibrillator with specialized features and...
- Research articles 2007-03-15
- Medicis Pharmaceutical Corporation Begins Trading on the New York Stock Exchange Under the Symbol "MRX"
- PHOENIX--BW HealthWire--September 23, 1998--Medicis Pharmaceutical Corporation (NASDAQ:MDRX) today announced its shares will begin trading on the New York Stock Exchange ("NYSE") under the symbol "MRX" at the opening bell tomorrow morning. At the request of the NYSE, the Company's trading symbol has been changed to "MRX" from the previously...
- Research articles 1998-09-23
- Philips HeartStart MRx Monitor/Defibrillator Chosen by Leading-Edge Emergency Medical Services Organizations across the U.S
- ANDOVER, Mass. -- Royal Philips Electronics (NYSE:PHG, AEX:PHI) today announced that several leading-edge U.S. emergency medical service EMS organizations have chosen the Philips HeartStart MRx - an advanced, reliable and easy-to-use monitor/defibrillator - to better support patient care and help improve cardiac emergency survival rates in the pre-hospital setting. The...
- Research articles 2005-01-13
- Metalrax Group PLC Announces Operating Results
- BIRMINGHAM, England--BUSINESS WIRE--Sept. 23, 1997-- Metalrax Group PLC (LDN:MRX), a U.K.-based specialty engineering company, today reported sharply improved operating results for its initial half year ended June 30, 1997. Results in this year's period reached record highs for the 27th time in a row. Net income...
- Research articles 1997-09-23
- Metalrax Group PLC Announces Strong Initial Half 1998 Operating Results
- BIRMINGHAM, England--BUSINESS WIRE--Sept. 22, 1998-- Firm Raises Semi Annual Dividend by 25% Metalrax Group PLC (LDN:MRX), a UK-based specialty engineering company, today reported sharply improved operating income on record revenues in its initial half...
- Research articles 1998-09-22
- Metalrax Group PLC Announces Record Profitability for Initial Half 2000; raises semi annual dividend by 10%
- Business Editors BIRMINGHAM, ENGLAND--BUSINESS WIRE--Sept. 26, 2000 Metalrax Group PLC (LDN:MRX), a UK-based specialty engineering company, today reported record operating income in its initial half year ended June 30, 2000. Reflecting this record-breaking first half performance, MRX's board of directors voted to raise the company's regular semi-annual...
- Research articles 2000-09-26
- Mobile E-Prescribing: The Killer App for IT Adoption
- Electronic prescribing constitutes the poor man's Electronic Medical Record EMR. This type of solution provides more than sufficient value at only a fraction of the EMR cost for physicians, clinicians and health providers who are rather averse of IT technology. The whitepaper explains in detail how mobile electronic prescribing, or...
- White papers 2005-05-06
- Robertson Stephens Reiterates Strong Buy Rating on MRX
- SAN FRANCISCO--BUSINESS WIRE--Oct. 21, 1999--
- Research articles 1999-10-21
- Unisphere Networks' MRX Multi-Service Edge Router Awarded Product of the Year by Network Magazine
- Business/Technology Editors
- Research articles 2002-04-18
- Medicis to Present at Wachovia Securities Equity Conference
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the 14th Annual Wachovia Securities Nantucket Equity Conference at the Harbor House Village in Nantucket, Massachusetts. A live webcast of its presentation scheduled for Thursday, June 24, 2004, at 10:45 a.m. Eastern Time (7:45 a.m....
- Research articles 2004-06-18
- Medicis to Present at UBS Global Life Sciences Conference
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the UBS Global Life Sciences Conference at The Grand Hyatt New York in New York City. A live webcast of its presentation scheduled for Tuesday, September 28, 2004, at 1:30 p.m. Eastern Time (10:30 a.m....
- Research articles 2004-09-23
- Medicis to Present at UBS Global Pharmaceuticals Conference
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the UBS 2005 Global Pharmaceuticals Conference at the Grand Hyatt New York in New York City. A live webcast of its presentation scheduled for Tuesday, May 24, 2005, at 1:30 p.m. Eastern Time (10:30 a.m....
- Research articles 2005-05-19
- Medicis Requests That Inamed Recommend Rejection of Allergan Exchange Offer
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that it has formally given notice to Inamed Corporation's (NASDAQ:IMDC) board of directors requesting it recommend to Inamed stockholders that they reject Allergan Inc.'s (NYSE:AGN) exchange offer. Allergan's publicly announced offer is to exchange all outstanding shares of Inamed for either $84 in...
- Research articles 2005-11-22
- Robertson Stephens Reiterates Strong Buy Rating on MRX
- Business Editors
- Research articles 2000-02-17
- Medicis to Present at Deutsche Bank 30th Annual Health Care Conference
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Deutsche Bank 30th Annual Health Care Conference in Baltimore, Maryland. A live webcast of its presentation scheduled for Wednesday, May 4, 2005, at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time), may be accessed...
- Research articles 2005-04-29
- Philips Announces FDA Clearance of Q-CPR™ - Providing Real-time CPR Measurement and Feedback
- ANDOVER, Mass. -- Cleared for Marketing on the Philips HeartStart MRx Monitor/Defibrillator, New Technology is Designed to Improve Delivery of CPR by Professional Medical Responders
- Research articles 2005-11-08
- Allergan Welcomes Inamed's Recommendation of Its Offer to Stockholders; Parties Look to Execute Merger Agreement and Close Transaction
- IRVINE, Calif. -- Allergan, Inc. (NYSE:AGN) today welcomed the announcement made by the Board of Directors of Inamed Corporation (NASDAQ:IMDC) that the Inamed Board recommends Allergan's offer to acquire Inamed. Earlier in the day, Inamed announced that Inamed and Medicis (NYSE:MRX) had terminated their previously executed merger agreement.
- Research articles 2005-12-13
- Medicis Announces FDA Approval of AMMONUL for Urea Cycle Disorder
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration ("FDA") has approved AMMONULR as an adjunctive therapy for the treatment of acute hyperammonemia and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. FDA granted AMMONULR orphan drug status with seven years...
- Research articles 2005-02-18
- Leerink Swann & Company Initiates Coverage of Medicis Pharmaceutical Corporation (NYSE: MRX)
- Yesterday after the close, Senior Specialty Pharmaceuticals Analyst, Gary Nachman, initiated coverage of Medicis Pharmaceuticals Corporation with an Outperform rating. His investment rating is based on the successful outcome of the proposed merger with Inamed Corporation, which he believes would increase the company's exposure to the high-growth cosmetics market. Mr....
- Research articles 2005-06-30
- Medicis to Present at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
- SCOTTSDALE, Ariz. -- Medicis (NYSE:MRX) today announced that the Company is scheduled to present at the Morgan Stanley Pharmaceutical CEOs Unplugged Conference in New York. A live webcast of its presentation scheduled for Thursday, January 5, 2006, at 6:45 a.m. Pacific Time (9:45 a.m. Eastern Time), may be accessed via...
- Research articles 2006-01-03
- << Previous
- page 1 of 3
- Next >>
